# CPX-351 Real-World Effectiveness and Safety Study

> **NCT05169307** · — · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 147 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** CPX-351

## Key facts

- **NCT ID:** NCT05169307
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-14
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2022-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05169307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05169307, "CPX-351 Real-World Effectiveness and Safety Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05169307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*